Introduction
In today’s highly regulated pharmaceutical industry, even the smallest compliance gap can create significant risks. A GxP Gap Analysis is one of the most powerful tools to identify weaknesses and strengthen operations before regulators do.
Key Points
- What is GxP Gap Analysis?
A systematic review of processes, systems, and documentation against Good Practices (GxP) standards. - Why It Matters
- Minimizes regulatory risk
- Ensures data integrity and patient safety
- Prepares organizations for FDA, EMA, and MHRA inspections
- The Coentic Strategic Advisors Approach
Our experts deliver tailored, actionable reports and clear remediation plans, helping organizations achieve sustainable compliance and operational efficiency.
Conclusion
Proactive GxP Gap Analysis is not just about passing audits—it’s about building a foundation of trust, safety, and long-term success.
